TrialsgrambetaRCTs are beautiful

SMART

2018

Isotonic Solutions and Major Adverse Renal Events Trial

In 15,802 ICU patients, balanced crystalloids reduced the composite of major adverse kidney events at 30 days versus saline.

Result

Efficacy: MAKE30 (death, RRT or persistent renal dysfunction)OR 0.91 · P = 0.04

Below 1 favours balanced crystalloids, above 1 favours saline.

Event rates
Absolute difference
1.1 points
NNT
91

Absolute difference and NNT are derived from the event rates.

Original publication
Subtopic
Balanced crystalloids
Design
Cluster-randomised crossover trial, Vanderbilt
Relevance
Important: one of several pillars.
Source
Semler MW, et al. N Engl J Med. 2018;378(9):829-839.doi 10.1056/NEJMoa1711584

Discussion & critique

Small absolute effect but a defensible default for balanced solutions in non-TBI ICU patients.

Discussed in podcasts